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Abstract Transcription factors of the cAMP response
element-binding protein (Creb)/cAMP response element mod-
ulator (Crem) family were linked to the switch from a con-
tractile to a proliferating phenotype in vascular smoothmuscle
cells (VSMCs). Here, we analyzed the vascular function of
Crem in mice with a global inactivation of Crem (Crem−/−).
CRE-mediated transcriptional activity was enhanced in pri-
mary Crem−/− VSMCs under nonstimulated conditions and
under stimulation with Forskolin and platelet-derived growth
factor (Pdgf) whereas stimulation with nitric oxide or cGMP
showed no effect. This elevated CRE-mediated transcriptional
activity as a result of Crem inactivation did not alter aortic
contractility or fractions of proliferating or apoptotic aortic
VSMCs in situ, and no impact of Crem inactivation on the
development of atherosclerotic plaques was observed. Crem−/
− mice exhibited an increased neointima formation after ca-
rotid ligation associated with an increased proliferation of
VSMCs in the carotid media. Pdgf-stimulated proliferation
of primary aortic Crem−/− VSMCs was increased along with
an upregulation of messenger RNA (mRNA) levels of Pdgf
receptor, alpha polypeptide (Pdgfra), cyclophilin A (Ppia),
the regulator of G-protein signaling 5 (Rgs5), and Rho
GTPase-activating protein 12 (Arhgap12). Taken together,
our data reveal the inhibition of Pdgf-stimulated proliferation
of VSMCs by repressing the Pdgf-stimulated CRE-mediated
transcriptional activation as the predominant function of Crem
in mouse vasculature suggesting an important role of Crem in
vasculoproliferative diseases.
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Introduction
cAMP response element-binding protein (Creb) and cAMP
response element modulator (Crem) are structurally related
transcription factors regulating the transcription of multiple
genes in response to cAMP, cGMP, and other second messen-
gers [33, 32]. Both transcription factors exhibit a notable
functional diversity through the existence of splice variants
and the formation of homodimers or heterodimers binding to
the cAMP response element (CRE; TGACGTCA and variants
thereof) in the promoter regions of their target genes [17, 25].
The phosphorylation of Creb at Ser-133 by the cAMP-
dependent protein kinase A (PKA) represents an important
mechanism of CRE-mediated transcriptional activation. In
contrast, a number of Crem variants, particularly small iso-
forms including inducible cAMP early repressor (Icer) and
small Icer (smIcer), suppress CRE-mediated transcriptional
activation [38, 26, 7]. These repressors contain the DNA-
binding domain enabling them to bind to the CRE; however,
they lack functional domains responsible for transactivation or
the inducibility by kinases [26].
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Cyclic AMP promotes quiescence and maintenance in
vascular smooth muscle cells (VSMCs) and the β-
adrenoceptor, and cAMP-dependent activation of PKA is
important to sustain their contractile function under normal
conditions [35]. Creb is an important downstream target of
PKA, and changes in Creb phosphorylation or function are
correlated with the regulation of cell proliferation [18, 41],
apoptosis [42], migration [15, 29], VSMC hypertrophy [8], or
vascular resistance [23]. Elevated cAMP levels inhibit
platelet-derived growth factor (Pdgf)-stimulated VSMC
grow th by PKA/Creb -dependen t i nduc t i on o f
transformation-related protein 53 (p53) and cyclin-dependent
kinase inhibitor 1A (p21) and by inhibition of mitogen-
activated protein kinase (MAPK) signaling [2, 11]. Several
studies showed the relevance of Creb for the regulation of
v a s cu l a r qu i e s c en ce and t h e d eve l opmen t o f
vasculoproliferative diseases [35, 14]. Schauer et al. reported
that downregulation of Creb is a common pathological re-
sponse to vascular injury and seems to contribute to plaque
progression [37]. It is suggested that most Crem isoforms
(including Icer and smIcer) act as repressors of CRE-
dependent gene transcription. Therefore, Crem might play
an important role as a counterpart of Creb in the vasculature.
Aldosterone-induced impaired vascular contractility re-
portedly goes along with diminished glucose-6 phosphate
dehydrogenase expression due to increased Crem levels
[22], and a transient overexpression of Icer inhibited neointi-
ma formation in balloon-injured rat carotid artery [28]. How-
ever, the physiological role of Crem in the intact vascular
system is fragmentary and has not yet been systematically
studied in knockout models.
In order to elucidate the general role of Crem in the vascu-
lature, we investigated the CRE-mediated transcriptional ac-
tivation in response to important stimuli in the vasculature,
namely nitric oxide (NO), cAMP, cGMP, and Pdgf in Crem
knockout mice (Crem−/−) and wild-type (Crem+/+) controls.
Since Pdgf and cAMP stimulation increased CRE-mediated
gene expression in Crem−/− vs. Crem+/+ VSMCs, we investi-
gated the relevance of enhanced CRE-mediated transcription
by Crem inactivation under physiological and pathological
conditions in the vasculature. In particular, the impact of Crem
inactivation on vascular contractility, plaque development
after high-fat diet, and neointima formation after vascular
injury by carotid ligation was assessed. Moreover, we ana-
lyzed apoptosis and proliferation rates of aortic VSMCs and
identified possible target genes of Crem relevant in this
context.
Material and methods
For detailed description of cell culture; transient transfection;
histological, histochemical, and immunofluorescence
imaging; and quantitative real-time PCR, see the expanded
material and methods part in the online supplement.
Experimental animals and materials The generation of
Crem mutant mice lacking the DNA-binding domains of
the Crem gene was published previously [3]. We thank
Dr. G. Schütz, DKFZ Heidelberg, Germany, for providing
Crem−/− mice. Crem−/− and Crem+/+ mice originated from
the same mouse colony which has been continued for
more than ten generations on the same mixed background
(129Sv:C57/Bl6). All animal experimentation was per-
formed in accordance with local animal welfare authori-
ties and approved by the LANUV-Regional Authority for
Nature, Environment and Consumer protection in North
Rhine-Westphalia, Germany (permit number: 8.87-
51.04.20.09.386 or 84.02.04.2011.A179). Surgery was
performed under isoflurane-nitrous oxide anesthesia, and
every effort was made to minimize suffering. All
chemicals were purchased from Sigma (Sigma-Aldrich
Chemie GmbH, Steinheim, Germany) as not stated
otherwise.
Analysis of aortic reactivity Aortic vascular tone was mea-
sured in male Crem−/− and Crem+/+ mice of 17–18 weeks.
Preparation and initial treatment of thoracic aortae as well
as mounting to the dual-wire myograph system (model
410A; J.P. Trading, Aarhus, Denmark) were described
before [19]. After 45 min of equilibration in a 10-ml bath
of physiologic salt solution (in mmol/l, 118 NaCl, 25
NaHCO3, 2.5 CaCl2, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4,
5.5 glucose, and 0.026 ethylene diamine tetraacetate) at
37 °C, aortic rings were stretched to a passive resting
tension of 17.5 mN, followed by several constrictions
induced by a high-potassium solution (K-PSS) composed
of (in mmol/l) the following: 25 NaHCO3, 2.5 CaCl2,
122.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 5.5 glucose, and
0.026 ethylene diamine tetraacetate. Vasoconstriction was
measured after stimulation with the α-adrenoceptor ago-
nist phenylephrine (PE) or prostaglandin F2α. Vasorelax-
ation was studied after precontraction with 1 μmol/l PE
and stimulation with the m-cholinoceptor agonist carba-
chol, the β-adrenoceptor agonist isoproterenol, or with the
nitrogen oxide donor sodium nitroprusside. Vasoconstric-
tions and relaxations (Fig. 3a, c–e) were determined as
first effects after K+ contractions except prostaglandin F2α
(PGF2α, second effect after PE contraction experiments)
followed by an injection of 1 μmol/l carbachol to test
endothelial response (exclusion criterion less than 70 %
re l axa t i on ) . PE- induced vasocons t r i c t i on and
precontractions for carbachol and sodium nitroprusside
were performed in the presence of 1 μmol/l propranolol
to exclude possible β-adrenergic effects of PE. For the
separate endothel ium-denuded experiments , the
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endothelium was removed by carefully rubbing a wire on
the inner side of the aortic rings. The successful endothe-
lium denudation was checked by the relaxation response
before and after denudation by 10−6 M acetylcholine
stimulation after norepinephrine (10−6 M) contraction.
All drugs were directly added to the bath. For treatment
of mice with isoprenaline, osmotic mini-pumps (model
2001, Alzet, Cupertino, USA) were implanted in mice
for continuous application of 10 mg/kg body weight/day
of isoprenaline (DL-isoprenaline hydrochloride) for 7 days
according to the manufacturer’s instructions.
Mouse carotid ligation model and sham operation Carotid
artery ligation model was performed with male Crem−/−
and Crem+/+ mice as a modification of the model pub-
lished by Kumar et al. [20, 21]. Mice were anesthetized
by intraperitoneal injection of avertin solution
(tribromoethanol 0.36 mg/g body weight with 2-
methyl-2-butanol 0.18 mg/g body weight). A midline
neck incision was made to expose the left and right
common carotid arteries. Sham operation was performed
on the left artery as a contralateral control, before the
right carotid artery was ligated by a 5-0 propylene
suture proximal to the carotid bifurcation. After 3 weeks
of recovery, mice were sacrificed and the carotid arteries
were excised and fixated overnight in neutral buffered
formaldehyde (4 %). Tissues were dehydrated and em-
bedded in paraffin as described above. Series of eight
5-μm sections were prepared on glass slides of the right
and left arteries. For the right ligated arteries, carotid
sections in a proximal distance to ligation of 0, 200,
400, 700, and 1000 μm were collected and stained for
morphometric evaluation with resorcin-fuchsin and nu-
clear fast red. For the sham-ligated left carotid arteries,
morphometric values were obtained from three different
slides and calculated as a mean for each vessel. For
immunohistochemical analysis, sections of the right ca-
rotid artery were investigated in a proximal distance to
ligation of 0–200 μm.
Statistics If not stated otherwise, data are expressed as
mean values±standard error of the mean (SEM) with n
indicating the number of independent experiments. In
cell culture experiments, the number of independent
transfections and the number of separate cells isolations
are indicated. For statistical evaluation, two-way
ANOVA and Tukey post hoc tests were used to com-
pare multiple groups. For comparison of two groups,
Student’s t test was conducted. Statistical differences
were considered as significant at p<0.05. All statistical
analyses were performed using SigmaPlot (version 11.2;
Systat Software, Erkrath, Germany) except the statistical
analysis of RT-PCR results and calculation of relative
expression ratios which were conducted by the relative
expression software tool (REST© Version 2.07) [30,
44].
Results
Increased CRE-dependent transcriptional activity in VSMCs
from Crem−/− mice after stimulation with cAMP or Pdgf At
first, we tested the effect of Crem inactivation on CRE-
mediated transcriptional activation in isolated primary aortic
VSMCs. Staining of these cells revealed a proportion >95 %
of the smooth muscle marker smooth muscle myosin heavy
chain (Myh11), while the marker of endothelial cells Von
Willebrand factor (Vwf) was detectable in less than 4 % of
the cells (Fig. 1a–e). CRE-dependent transcriptional activity
was measured after transient transfection of VSMCs with a
CRE-controlled reporter gene plasmid and subsequent stimu-
lation with activators of the cAMP- (Forskolin, a direct
receptor-independent activator of the adenylyl cyclase) or
cGMP-dependent (8-pCPT-cGMP and S-nitroso-N-
acetylpenicillamine (SNAP)) signaling cascades or in re-
sponse to the growth factor Pdgf. Cells were stimulated with
different concentrations of Forskolin (3×10−8–3×10−5 mol/l),
or DMSO (1 mmol/l) as solvent control. (Fig. 1f). Forskolin
increased the CRE-controlled promoter activity in a
concentration-dependent manner in both groups. However,
Crem inactivation led to an enhanced induction of CRE-
controlled transcriptional activity after stimulation with 3×
10−6 to 3×10−5 mol/l Forskolin; nonstimulated VSMCs of
Crem−/− mice showed a significant 1.5-fold increase in the
CRE-controlled transcriptional activity (Fig. 1g; p<0.05).
Hence, the inactivation of Crem in Crem−/− mice was associ-
ated with an increased CRE-dependent transcriptional activity
both in response to Forskolin and under basal conditions in
aortic VSMCs. Stimulation with the cGMP analogon 8-pCPT-
cGMP (9 h; 10−4 M) or with the NO donator SNAP (9 h;
10−4 M) did not reveal an increase in CRE-mediated transcrip-
tional activity versus nonstimulated control conditions in both
genotypes (Fig. 1h, i). Stimulation with the growth factor Pdgf
(9 h; 7.5 ng/ml) exclusively increased the CRE-mediated gene
expression in Crem−/− VSMCs while Pdgf had no effect in
Crem+/+ cells, indicating that Crem can completely block the
impact of Pdgf on CRE-dependent gene expression (Fig. 1j).
No morphological differences and an unaltered rate of apo-
ptotic or proliferating aortic VSMCs in the aorta of Crem−/−
mice The increased CRE-mediated transcriptional activation,
in particular under basal, nonstimulated conditions (Fig 1g) in
Crem−/− mice raised the question whether inactivation of
Crem is associated with functional alterations in the mouse
vasculature. However, histological analysis of aortae from
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Crem−/− mice did not show any differences in comparison to
Crem+/+ mice. There was no change in the thickness of the
media (Crem+/+, 53±1 μM, n=3; Crem−/−, 54±4 μM, n=3).
In order to assess possible effects of Crem inactivation on
important functions of aortic smooth muscle cells, we studied
the impact of Crem inactivation on the fraction of apoptotic
Fig. 1 Characterization of VSMC culture by immunofluorescence
staining (a–e). Photographs of isolated VSMCs incubated with an
antibody against the a smooth muscle myosin heavy chain (Myh11), b
Von Willebrand factor (Vwf), c the secondary antibody control without
primary antibody, and d positive control of the Vwf antibody in aortic
sections; note the positive red staining of the endothelium. e
Quantification of the proportion of stained cells based on 350 analyzed
cells revealed over 95 % positive staining of the cells by the VSMC
marker Myh11; scale bar 100 μm. f–j CRE-mediated transcriptional
activation of isolated VSMCs from Crem+/+ (white symbols) and
Crem−/− (black symbols) mice. VSMCs were transiently transfected with
a CRE-controlled luciferase reporter gene construct and treated with
activators of different signaling cascades or solvent controls (Ctr). f
Forskolin (in DMSO, n=8/6 meaning eight independent transfections
from six isolations, for 12 h; Ctr: n=15–18/6), h 10−4 M 8-pCPT-
cGMP (in H2O, n=6/6, for 9 h), i 10
−4 M SNAP (in H2O, n=7/7, for
9 h), and j 7.5 ng/ml Pdgf (in H2O, n=5/5, for 9 h). Data were presented
relative to the mean of Crem+/+ Ctr, which was set to 1. Note the elevated
CRE-dependent transcriptional activity under stimulation with 3×10−8–
3×10−5 M Forskolin (f) and Pdgf (j) in VSMCs of Crem−/− mice.
Independent analysis of untreated transfected VSMCs (g) revealed a
1.5-fold increase in VSMCs from Crem−/− vs. Crem+/+ mice (n=51–54/
3). Asterisk (*) denotes p<0.05 vs. Crem+/+, a cross (+) denotes p<0.05
vs. control
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and proliferating aortic VSMCs. There were no significant
differences between Crem−/− and Crem+/+ mice regarding
both the basal proliferation rate and the proportion of apopto-
tic cells of VSMCs (Fig. 2).
Unaltered regulation of aortic vascular tone in Crem−/−
mice Vascular tone was studied in aortic rings from Crem−/−
and Crem+/+ mice in a wired myograph system.
Concentration-dependent vasoconstriction was measured
Fig. 2 Detection of proliferating VSMCs (top) in aortic sections from
Crem−/− and Crem+/+ mice (A3–D3 and A4–D4). Photomicrographs show
the following: DAPI cell nuclei staining (A1–4), proliferating VSMCs
detected by a Ki-67 antibody (B1–4; white arrows), the endogenous
fluorescence (C1–4), and the overlay (D1–4). As a positive control,
spleen tissue sections with a high proliferation rate were stained with
the Ki-67 antibody (A1–D1) and were incubated as a negative control
without the first Ki-67 antibody (A2–D2) (bottom). Detection of apoptotic
VSMCs in aortic sections from Crem+/+ and Crem−/− mice (A3–D3 and
A4–D4). Photomicrographs show the following: the cell nuclei stained
with DAPI (A1–4), the apoptotic VSMCs detected by a TUNEL assay
(B1–4; white arrows), VSMCs visualized by a smooth muscle actin-
specific antibody (C1–4), and the overlay (D1–4). As a positive control,
aortic sections were treated with DNase I (A1–D1), and as a negative
control, sections were treated without enzyme (A2–D2). Statistical anal-
ysis of the frequency of apoptotic cells in the aortic sections of Crem+/+
(white) and Crem−/− (black) mice revealed no significant differences in
the fraction of proliferating or apoptotic VSMCs in the aorta (right); n=3
based on 5960±550 cells for detection of proliferating cells and 6030±
220 cells for detection of apoptotic cells in each group, respectively
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under stimulation with the α1-adrenoceptor agonist phenyleph-
rine (PE, Fig. 3a) or with prostaglandin F2α (PGF2a, Fig. 3b).
Vasodilatation was studied after precontraction with 1 μmol/l
PE and application of increasing concentrations of the β-
adrenoceptor agonist isoproterenol (ISO, Fig. 3c). NO-
dependent vasodilatation was measured under stimulation with
both the endothelium-dependent NO-releasing m-
cholinoceptor agonist carbachol (CAR, Fig. 3d) or the
endothelium-independent NO donor sodium nitroprusside
(SNP, Fig. 3e). Overall, there were no significant differences
between groups, neither in maximum or in minimum wall
tension of contraction or relaxation nor in the half maximal
effective concentration (EC50)/half maximal inhibitory concen-
tration (IC50) values (see supplemental Fig. S1). To exclude
endothelium-dependent effects, aortic contractility was also
studied in denuded aortae after PE, ISO, CAR, and SNP
stimulation (Fig. 3f–i). Moreover, contractility was measured
after 7 days of isoproterenol administration in intact and
denudated aortae (Fig. 3j–m). Denudation showed a marked
impact on aortic contractility. PE showed a higher potency
reflected by a left shift of the dose-response curve. The relax-
ation after ISO or CAR treatment was markedly impaired after
Fig. 3 Cumulative drug-induced
contractions and relaxations in
wall tension of aortic rings (a–e),
relative wall tensions after denu-
dation (triangles) compared to
intact aortae (circle) without (f–i)
and with 1 week of chronic iso-
proterenol treatment (j–m) in
Crem+/+ (open symbols) and
Crem−/− (filled symbols) male
mice. Curves in dark gray (j–m)
show data of untreated aortae (f–
i). The vascular tone was mea-
sured in response to stimulation
with the α-adrenoceptor agonist
phenylephrine (a, f, j;PE, n=4–6)
and prostaglandin F2α (b; PGF2α,
Crem+/+ n=4, Crem−/− n=3). Re-
laxations were induced after
preconstriction with PE (1 μmol/
l) by the β-adrenoceptor agonist
isoproterenol (c, g, k; ISO; n=4–
6), the muscarinic receptor ago-
nist carbachol (d, h, l;CAR; n=5–
8), and the nitric oxide donor so-
dium nitroprusside (e, i, m; SNP;
n=4–9). No significant differ-
ences between Crem+/+ and
Crem−/− mice were observed
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denudation, while SNP treatment showed a slight increase in
efficiency and potency. Isoproterenol treatment showed a sim-
ilar but less pronounced effect on PE, ISO, and CAR dose-
response curves which could be superimposed by denudation,
while the chronic isoproterenol treatment had no effect on the
SNP-stimulated relaxation. However, both denudation of aortic
rings as well as isoproterenol treatment and their combination
showed no difference between Crem−/− and Crem+/+ mice.
Unaltered plaque development in Crem−/− × ApoE−/−
mice After analysis of basal morphological and physiological
functions, we investigated the impact of Crem inactivation in
atherosclerotic plaque development in aortae on an ApoE
knockout (ApoE−/−) background and in a model of vascular
injury by carotid ligation. Red oil O staining of aortae revealed
no difference in plaque area in Crem−/− × ApoE−/− compared
to Crem+/+ × ApoE−/− mice after 20 weeks of high-fat diet,
Fig. 4 Analysis of neointima
formation of the right carotid artery
3 weeks after ligation. a Resorcin-
fuchsine and nuclear fast red stain-
ing of the cross sections of the
ligated right and sham-operated left
carotid artery from Crem+/+ and
Crem−/− mice. b Downregulation
of relative Crem mRNA levels in
Crem+/+ sham (n=6) and ligated
carotids (n=4). Quantification of
neointima (c) andmedia area (d) in
Crem+/+ (white, n=10) and Crem−/
− mice (black, n=9). Note the se-
vere increase in neointima forma-
tion in the Crem−/−mice. e Icam1-
and Vcam1-specific immunofluo-
rescent staining of carotid cross
sections of ligated carotids from
Crem+/+ and Crem−/− mice. Quan-
tification of Icam1- (f) and Vcam1
(g)-stained area showed no differ-
ences between the genotypes.
*p<0.05 vs. Crem+/+ (post hoc
tests, two-way ANOVA). h De-
tection of proliferating VSMCs in
the cross sections of ligated ca-
rotids. Photomicrographs show the
following: the cell nuclei stained
with DAPI, proliferating cells
(VSMCs) detected by a Ki-67 an-
tibody (white arrows), visualiza-
tion of VSMCs with a smooth
muscle actin-specific antibody,
and the overlay. Crem−/− VSMCs
showed an increase in the per-
centage of proliferating VSMCs in
the media but not in the neointima
(for details, see text). Scale bars=
100 μm
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while a slight 7 % increase after 30 weeks of high-fat diet was
observed. The control groups showed small red oil O-positive
areas with no differences between genotypes after 30 weeks of
standard diet (supplemental Fig. S2A, B). A detailed analysis
Fig. 5 Detection of proliferating and apoptotic cells in primary isolated
VSMCs from Crem+/+ (white bars) and Crem−/− (black bars) mice. a
Immunofluorescence images of VSMCs stained with DAPI and a Ki-67
antibody to detect proliferating cells after stimulation with Pdgf
(7.5 ng/ml, 24 h) compared to control conditions without stimulation
(Ctr). b Quantitative analysis showed an increase in the percentage of
proliferating VSMCs in Crem−/− vs. Crem+/+ VSMCs in the Pdgf-treated
groups (n=14/5). c Percentage frequency of apoptotic VSMCs was
detected by TUNEL assay after 24-h stimulation with increasing concen-
trations of hydrogen peroxide. No differences between the genotypes
were observed (n=10/6). d Impedance-based real-time proliferation
curves of vehicle-treated (triangle) and Pdgf (7.5 ng/ml)-treated VSMCs
(circle) of Crem−/− (n=8; black) and Crem+/+ VSMCs (n=8; white)
normalized to the time point before Pdgf treatment (e). The differential
proliferation curves of Pdgf-treated minus Pdgf-untreated VSMCs and
the calculation of the f maximum cell index (ΔCImax; square) and the g
time to the maximum (TΔCImax) are shown (all n=8). Note the increased
proliferation rate in Pdgf-stimulated Crem−/− compared to Crem+/+
VSMCs, represented by the increased cell index of proliferation curves
and the higherΔCImax values, while the time toΔCImax was not changed.
Asterisk (*) denotes p<0.05 vs. Crem+/+, and the cross (+) denotes
p<0.05 vs. control conditions. For statistical analysis of proliferation
curves, a two-way repeated measures ANOVA and Tukey post hoc tests
were used
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of the root of the aortic arch showed no difference in the main
plaque area and the area-positive macrophage staining (sup-
plemental Fig. S2C, D). Moreover, no differences were found
in the proliferation rate of VSMCs in the media (Crem+/+ ×
ApoE−/− 0.48±0.17 vs. Crem−/− × ApoE−/− 0.32±0.17 %
VSMCs) and in the proliferation rate of all cell types in the
plaques (Crem+/+ × ApoE−/− 4.1±0.5 vs. Crem−/− × ApoE−/−
3.7±0.8 % VSMCs; see supplemental Fig. S2F). Analysis of
cell content showed a comparable cell density in the media
(Crem+/+ × ApoE−/− 3844±453 vs. Crem−/− ×ApoE−/− 3120±
228 cells/mm2) and the plaques (Crem+/+ × ApoE−/− 3190±
244 vs. Crem−/− × ApoE−/− 3331±389 cells/mm2) between
the genotypes. Measurement of triglycerides, high- and low-
density lipoprotein (HDL and LDL, respectively) and choles-
terol revealed no differences between the genotypes (see
supplemental Fig. S3). Overall inactivation of Crem had a
minor impact on the progression of plaque development.
Increased neointima formation after ligation of carotids in
Crem−/− mice Crem−/− mice showed a severe increase in
neointima formation (Fig. 4a, c) when compared to Crem+/+
mice, while elevation of media thickness compared to the
sham controls remained equal between the genotypes
(Fig. 4d). Quantification of relative Crem messenger RNA
(mRNA) levels revealed a 48 % decrease in sham versus
ligated WT carotids (Fig. 4b). Furthermore, no difference in
the expression of intercellular adhesion molecule 1 (Icam1)
and vascular cell adhesion molecule 1 (Vcam1) was observed
between genotypes (Fig. 4d–f). The increased neointima for-
mation in Crem−/− mice was accompanied by a significant
increase of proliferating VSMCs in the media (Crem+/+ 0.11±
0.06 vs. Crem−/− 0.79±0.26 % VSMCs) but not in the neoin-
tima (Crem+/+ 4.5±2.5 vs. Crem−/− 1.9±0.7 % VSMCs; see
Fig. 4g). Separate analysis of cell content showed a compara-
ble cell density in the media (Crem+/+ 4451±259 vs. Crem−/−
4931±195 cells/mm2) and the neointima (Crem+/+ 6374±488
vs. Crem−/− 6648±1484 cells/mm2) between genotypes.
Increased fraction of proliferating primary VSMCs but unal-
tered fraction of apoptotic VSMCs in Crem−/− mice Since an
elevated proliferation rate of VSMCs was observed in the
ligated carotids, we studied effects of Crem inactivation in
primary VSMCs both under basal conditions and under stim-
ulation of proliferation with Pdgf. There was no difference in
the proliferation under nonstimulated control conditions.
Stimulation with Pdgf (7.5 ng/ml) for 24 h increased the
number of proliferating cells in both genotypes (Fig. 5a, b).
Under this condition, the proportion of proliferating cells was
1.3-fold higher in Crem−/− vs. Crem+/+ VSMCs. Furthermore,
we studied the rate of apoptotic VSMCs under basal condi-
tions and after triggering apoptosis with H2O2. H2O2 signifi-
cantly increased the rate of TUNEL-positive cells in a
concentration-dependent manner in both groups (Fig. 5c).
However, there were no differences between genotypes. To
substantiate the finding of increased VSMC proliferation rate
in Crem−/− mice, we measured cell growth in an impedance-
based Real-Time Cell Analyzer (RCTA). Again, cell growth
of Crem−/− VSMCs was elevated compared to Crem+/+ under
stimulation with Pdgf, while proliferation rate under basal
condition was unaltered (Fig. 5d). This was also represented
by the differential proliferation curves of Pdgf-treated and
Pdgf-untreated cells (Fig. 5e) and the 2-fold higher maximum
cell index (CI), while the time point of the maximum CI was
not altered (Fig. 5f, g).
To identify genes which are differentially regulated be-
tween the Pdgf-stimulated VSMCs of Crem−/− and Crem+/+
mice, a microarray analysis was performed (data not
shown). Verification of putative-regulated genes by quan-
titative real-time PCR analysis (Table 1, n=5) revealed an
upregulation of Rho GTPase-activating protein 12
(Arhgap12), cyclophilin A (Ppia), the regulator of G-
protein signaling 5 (Rgs5), and the Pdgf receptor, alpha
polypeptide (Pdgfra) mRNA in Pdgf-stimulated VSMCs
from Crem−/− vs. Crem+/+ mice. Other genes which tended
to be upregulated comprise the fibroblast growth factor 18
(Fgf18), angiotensin II, type I receptor-associated protein
(Agtrap), and TAF12 RNA polymerase II, TATA box-
binding protein (TBP)-associated factor (Taf12).
Rgs5 mRNA levels were also upregulated in untreat-
ed aortae of Crem−/− compared to Crem+/+ mice, while
the mRNA levels of the other genes were unaltered
(Table 2, n=11–12).
Discussion
In this study, we systematically analyzed the relevance of the
cAMP-mediated transcription factor Crem in the vasculature
under physiological and pathophysiological conditions. Main
results of the functional inactivation of Crem comprise the
following: (i) an increased CRE-mediated transcriptional ac-
tivation under basal conditions and in response to stimulation
with Forskolin and Pdgf in isolated primary VSMCs. (ii) The
enhanced CRE-mediated transcription was not associated
which a major impact in the following: the physiology of
aortic VSMCs under basal conditions, aortic contractility,
and plaque development after high-fat diet. (iii) Contrary to
this inconspicuous phenotype, a severe increase of neointima
development after carotid ligation was observed, which was
accompanied by an elevated proliferation rate of VSMCs in
the media. (iv) In accordance to this finding, an increased
amount of proliferating VSMCs under stimulation with Pdgf
in isolated VSMCs was observed. Hence, we showed that as a
predominant function in VSMCs, Crem represses the Pdgf-
activated CRE-mediated gene transcription, which is
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particularly important for the regulation of proliferation, sug-
gesting an important role of Crem in vasculoproliferative
diseases.
To evaluate the functionality of the inactivation of Crem in
VSMCs and to exclude possible compensatory effects of other
transcription factors acting at CREs, we analyzed the CRE-
mediated transcriptional activity in response to Forskolin to
stimulate the cAMP-dependent signaling cascade. Such com-
pensatory effects were previously observed in different genet-
ic mouse models [3, 13, 9]. For experiments, isolated VSMCs
of low passages (<2) and high purity over 95 % of Myh11-
positive cells were used to minimize effects of phenotypic
modulation [5] and contamination of other cell types, e.g.,
endothelial cells. Crem inactivation in VSMCs increased
CRE-mediated transcriptional activity, likely as a conse-
quence of a derepressed activity of CREB or other activating
transcription factors like activating transcription factor 1
(ATF1). Therefore, Crem isoforms appear to have predomi-
nantly inhibitory functions in VSMCs and the increase in
CRE-mediated gene expression underscores the functionality
of the Crem inactivation and excludes the possibility that a
lacking vascular phenotype of Crem−/− mice under basal
conditions is due to a full compensation within the Creb/
Crem family of transcription factors. Besides, the cAMP-
dependent signaling NO and the soluble guanylate cyclase/
cGMP signaling cascade have been suggested to phosphory-
late Creb either by activation of mitogen-activated kinases or
by direct phosphorylation of Creb (for review, see [31]).
Steinbicker et al. reported that treatment of rat pulmonary
artery cells with the NO donor S-nitroso-glutathione induced
the Crem isoform Icer by activated CRE-mediated gene ex-
pression [40]. These results suggest that NO is a potent regu-
lator of CRE-mediated gene expression. However, using the
NO donor SNAP or a cGMP analogon, we did not find an
induction or differences of CRE-mediated gene expression in
the primary aortic VSMCs, indicating a minor role of NO for
CRE-dependent gene expression in murine aortic VSMCs
under our experimental conditions. However, stimulation of
VSMCs with Pdgf revealed an increase of CRE-mediated
gene expression in the Crem−/− VSMCs which was complete-
ly blunted in the Crem+/+ cells. This indicates that the stimu-
lation with Pdgf activates CRE-mediated gene expression, but
this mechanism is controlled by Crem.
Since cAMP-dependent CRE-mediated gene expression
was already increased in Crem−/− aortic VSMCs under basal
physiological conditions, we first studied the impact of Crem
inactivation on aortic contractility, VSMC proliferation, apo-
ptosis, and morphological abnormalities with regard to possi-
ble physiological changes. Previous findings by catheteriza-
tion of the left ventricle showed that Crem−/− mice exhibit a
lower left-ventricular blood pressure than Crem+/+ animals
[27], which could be associated with alterations in the con-
tractility of the vascular system. Moreover, a loss of the Creb
isoforms α andΔ was linked to a higher pulmonary vascular
resistance [23]. Our analysis revealed that neither the PE- or
prostaglandin-mediated vasoconstriction nor the β-adrener-
gic, muscarinic, or NO-dependent vasorelaxation was differ-
ent concerning the maximal effects or the EC50/IC50 in Crem
−/
− mice versus Crem+/+ mice. Furthermore, no differences in
contractility of Crem−/− mice versus Crem+/+ mice could be
detected in endothelium-denuded aortae and in aortae of
1 week isoproterenol-treated animals. Consequently, our data
indicate that Crem-derived transcription factors do not play an
important role in the regulation of proteins responsible for the
regulation of the aortic contractility, on the one hand, in both
VSMCs and endothelial cells and, on the other hand, under
basal and catecholamine-induced stress conditions reflected
by the isoproterenol-treated animals. Detailed morphological
and immunohistochemical analysis did not show any differ-
ences in the macroscopic appearance, media thickness,
Table 1 Expression analysis of selected genes in VSMCs of Crem−/−
and Crem+/+ mice stimulated with 7.5 ng/ml Pdgf-BB by quantitative
real-time PCR
Gene Relative expression Standard error p value
Hprt 1.054
Ywhaz 0.949
Ppia 1.450 1.13–1.87 0.004 up
Arhgap12 1.675 1.29–2.24 0.006 up
Rgs5 2.562 1.27–4.81 0.009 up
Pdgfra 1.568 1.09–2.55 0.026 up
Taf12 1.458 0.93–2.23 0.052
Fgf18 1.716 0.92–2.81 0.054
Agtrap 5.125 0.73–20.88 0.062
Relative expression ratios, standard error, and statistical analysis were
calculated by the relative expression software tool (REST© Version
2.07). An upregulation indicates an elevated amount of mRNA in the
Crem−/− VSMCs (n=5)
Table 2 Expression analysis of selected genes in the aorta of Crem−/−
and Crem+/+ mice by quantitative real-time PCR
Gene Relative expression Standard error p value
Hprt 1.000
Ppia 1.102 0.74–1.67 0.454
Arhgap12 1.049 0.42–2.50 0.858
Rgs5 1.909 0.87–4.11 0.011 up
Pdgfra 0.984 0.52–1.85 0.934
Taf12 0.945 0.53–1.76 0.779
Fgf18 0.801 0.44–1.51 0.245
Agtrap 1.043 0.43–2.45 0.875
Relative expression ratios, standard error, and statistical analysis were
calculated by the relative expression software tool (REST© Version
2.07). An upregulation indicates an elevated amount of mRNA in the
Crem−/− aortae (n=11–12)
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proliferative activity, and apoptotic rate of VSMCs in aortic
sections. Although these experiments only showed the condi-
tion in the adult animal, one can deduce that Crem also is not
essential for development in general and especially in the
formation of the contractile apparatus during mouse embryo-
genesis. Taken together, the basal increase in CRE-mediated
gene expression in Crem−/−mice particularly had no effect on
the physiology of the vasculature and the quiescence of
VSMCs.
Stimulation of VSMCs with Pdgf revealed an increase of
CRE-mediated gene expression in the Crem−/−VSMCs which
was completely blunted in the Crem+/+ cells. This indicates
that Crem is able to completely suppress the Pdgf-dependent
CRE-mediated gene expression. Hence, conditions of elevat-
ed Pdgf release should generate an increased CRE-mediated
gene expression in VSMCs with possible consequences for
cellular physiology. We tested this hypothesis in vivo in the
pathophysiological models of atherosclerotic plaque develop-
ment in Crem × ApoE−/− mice and the ligation of the carotid
artery, which are associated with increased Pdgf production
[47, 34, 6]. Despite Crem−/− × ApoE−/− mice showing a slight
increase of plaque burden after 30 weeks of high-fat diet, a
detailed analysis of plague development revealed no differ-
ences between Crem−/− × ApoE−/− and Crem+/+ × ApoE−/−
mice. Ligation of the carotid artery in Crem+/+ mice was
associated with a marked downregulation of Crem mRNA
levels, supporting the relevance of Crem in this context.
Accordingly, the complete inactivation of Crem led to a severe
increase of neointima formation in the Crem−/− mice associ-
ated with an increased proliferation rate of VSMCs in the
media. This corroborates to results of Herring et al. showing
that the majority of neointima-forming cells are derived from
differentiated medial smooth muscle cells [12]. Although
endothelium-mediated effects could not be excluded in this
context, levels of Icam and Vcam reflecting endothelium
activation via inflammatory mediators [43] showed no differ-
ences between the genotypes. Primary VSMCs of Crem−/−
mice exhibited a higher amount of proliferative cells after
stimulation with Pdgf. Therefore, the increased neointima
formation could be explained mainly by the elevated capacity
of Crem−/− VSMCs to proliferate. These findings fit well with
results in rats suggesting that an adenoviral expression of the
Crem isoform Icer inhibits VSMC proliferation and at least
contributes to the effects of Crem in vasculature [28].
In primary Pdgf-stimulated Crem−/− VSMCs, we found an
upregulation of the Pdgf receptor, alpha polypeptide (Pdgfra)
compared to Crem+/+ controls. Pdgf signaling via Pdgf recep-
tors (Pdgfrs) plays an important role in the formation of the
neointima after vascular injury, and administration of a Pdgfra
antibody reduces neointima development in an allograft mod-
el in rats [34, 24]. Furthermore, Pdgfra levels increase during
aging associated with an increase of proliferative response and
increased neointima formation after wire injury [45]. Watson
et al. showed that Pdgfra levels were inversely regulated to the
Creb content in SMCs [46]. Since short Crem isoforms, acting
as transcriptional repressors, can be rapidly induced via acti-
vated Creb/CRE-mediated signaling cascades [26, 38], Pdgfra
content could be inversely regulated via an activator (Creb)-
induced inhibitor (Crem) regulatory loop.
Moreover, cyclophilin A (Ppia) mRNA was increased in
Crem−/− VSMCs and is therefore associated with a higher
proliferation rate. Since Ppia is a possible target gene of Creb
[48], it might be activated by the inactivation of the repressor
Crem. Ppia overexpression in VSMCs increases neointima for-
mation and is involved in VSMCmigration and proliferation as
well as inflammatory cell accumulation [36], corroborating with
our observations. Interestingly, we observed an upregulation of
the regulator of G-protein signaling 5 (Rgs5) mRNA. The
regulator of G-protein signaling 5 is a highly and differentially
expressed member of the G-protein signaling (Rgs) proteins in
the arterial smooth muscle. In a model of β2-adrenoceptor
overexpression or after isoproterenol treatment, Rgs5 is upreg-
ulated in atria [16]. This links the expression of Rgs5 to cAMP-
dependent signaling, and indeed, we found an upregulation of
Rgs5 in the aortae of Crem−/− mice, which exhibit an increased
cAMP-dependent gene expression. The role of Rgs5 in the
vasculature is not understood in detail so far. Rgs5 is downreg-
ulated under Pdgf stimulation, and this downregulation was
linked to an overall activation of smooth muscle cells associated
with an activation of Gqα/Giα signaling, increased migration,
hypertrophic response, and vascular remodeling [10]. Cho et al.
showed that Rgs5 is upregulated during maturation and acts as a
potent GTPase of Gqα/Giα signaling [4]. Arnold et al. reported
an increased abundance of Rgs5 in growing collateral arterioles
during arteriogenesis and a 70% decreased neointima formation
in Rgs5-deficient mice. They suggested that Rgs5 shifts Gαq/11
signaling towards a Gα12/13-mediated Rho kinase-dependent
SMC activation [1] and Rho kinase inhibition was found to
decrease neointima formation [39]. However, the specific roles
of, e.g., Rgs5, Pdgfra, and Ppia and their possible mutual
interdependencies need further evaluation.
In conclusion, Crem−/− mice represent a valuable genetic
mouse model to study the functional consequences of in-
creased CRE-mediated transcriptional activation in vascula-
ture. Crem is a potent repressor of Pdgf-CRE-mediated sig-
naling associated with inhibition of proliferation in VSMCs.
Moreover, our experiments show that Crem is an important
regulator of gene expression under pathophysiological condi-
tions, associated with increased Pdgf release, like vascular
injury.
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